Assessment indicators included tumour weight and inhibition rate, spleen and thymus indices, serum cytokine levels (IL-2, IL-12, TNF-α, IL-10), as well as the phagocytic rate and phagocytic index of peritoneal macrophages. This evidence concerns the gene IL2 and neoplasm.